Polarean Imaging PLC (AIM:POLX, OTC:PLLWF), a leader in advanced MRI technology, has been selected as a featured company and poster presenter at the upcoming American Thoracic Society's 2024 Respiratory Innovation Summit.
A key gathering for those involved in pulmonary medicine, the event, which takes place from May 17-18 in San Diego, brings together over 275 global leaders from various sectors including start-ups, venture capital, and academia.
"As we strive to advance our commercialisation strategy, the increase in Xenon MRI posters and presentations marks significant strides in amplifying understanding and enthusiasm for Xenon MRI and the spectrum of therapeutic disciplines that could benefit from our technology," said CEO Christopher von Jako.
Afterwards, Polarean's executive team will attend the ATS International Conference from May 19-22 at booth 2813.
This year, Xenon MRI research will have a record presence, with 33 presentations from 10 sites covering a range of pulmonary conditions.